Cargando…
Assessment of γ-H2AX levels in circulating tumor cells from patients receiving chemotherapy
Circulating tumor cells (CTCs) are prognostic markers in a variety of solid tumor malignancies. The potential of CTCs to be used as a “liquid biopsy” to monitor a patient’s condition and predict drug response and resistance is currently under investigation. Using a negative depletion, enrichment met...
Autores principales: | Garcia-Villa, Alejandra, Balasubramanian, Priya, Miller, Brandon L., Lustberg, Maryam B., Ramaswamy, Bhuvaneswari, Chalmers, Jeffrey J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480704/ https://www.ncbi.nlm.nih.gov/pubmed/23112954 http://dx.doi.org/10.3389/fonc.2012.00128 |
Ejemplares similares
-
Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis
por: Wu, Yongqi, et al.
Publicado: (2016) -
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
por: Lustberg, Maryam B, et al.
Publicado: (2014) -
Genome Instability and γH2AX
por: Georgoulis, Anastasios, et al.
Publicado: (2017) -
Association of γH2AX at Diagnosis with Chemotherapy Outcome in Patients with Breast Cancer
por: Yang, Sherry X., et al.
Publicado: (2017) -
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
por: Wesolowski, Robert, et al.
Publicado: (2020)